If you liked this article you might like

4 Biotech Names That Could Be M&A Targets
Stock Picks Are Hard to Find as Small-Caps Struggle
3 Biotechs Screaming 'Takeover Target'
Trying to Knock Out Some Individual Trades, but it Is not Easy